LMIM
ATRC icon

Lockheed Martin Investment Management’s AtriCure ATRC Stock Holding History

Lockheed Martin Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-36,250
Closed -$811K – 128
2017
Q3 		$811K Hold
36,250
– – 0.04% 110
2017
Q2 		$879K Sell
36,250
-27,250
-43% -$579K 0.05% 116
2017
Q1 		$1.22M Buy
+63,500
New +$1.11M 0.07% 107

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Lockheed Martin Investment Management's ATRC Position: Q4 2017 in Review

Lockheed Martin Investment Management sold out of AtriCure (ATRC) in Q4 2017, closing a stake of 36,250 shares — an estimated $811K sold.

Lockheed Martin Investment Management first reported a position in ATRC in Q1 2017 and held it in 3 quarters. The position peaked at $1.22M in Q1 2017. 109 funds tracked by Wall St. Rank hold ATRC as of Q4 2017.

  • Lockheed Martin Investment Management reported no remaining AtriCure position as of Q4 2017 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 36,250 AtriCure shares in Q4 2017, an estimated $811K.
  • Lockheed Martin Investment Management first reported a position in AtriCure in Q1 2017 and held it in 3 quarters.
  • Lockheed Martin Investment Management's AtriCure position peaked at $1.22M in Q1 2017.
  • 109 funds tracked by Wall St. Rank held AtriCure as of Q4 2017.

Based on Lockheed Martin Investment Management's 13F filing for Q4 2017, filed 18 Jan 2018.